Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Compounded versions of semaglutide, the active ingredient ... Scott Brunner, CEO of the Alliance for Pharmacy Compounding, a group representing pharmacies that make compounded drugs, noted in ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

Compounded drugs are made by pharmacies or manufacturers other than the companies that make FDA-approved versions of the medicines, and they typically are allowed when drugs are in shortage.

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Compounded semaglutide: Medication produced by compounded pharmacies ... A telehealth provider that can prescribe GLP-1 ...

You can now get a prescription for weight loss drugs like Ozempic from an online telehealth Visit. But iis it safe?"It’s hard ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

Amid a decade-high surge in drug shortages, the American Medical Association has adopted new policy measures aimed at addressing the crisis.

Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.